Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
20.90
+0.60 (2.96%)
At close: Mar 27, 2026
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 9.55 billion as of March 27, 2026.
Market Cap
9.55B
Enterprise Value
8.39B
Revenue
146.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.90
Market Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 9.55B, a decrease of -63.49%. That is a compound annual growth rate of -80.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 9.27B | -33.75% |
| Dec 31, 2025 | 14.00B | -46.48% |
| Aug 15, 2025 | 26.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 14.65B |
| Nanjing Leads Biolabs | 13.67B |
| Everest Medicines | 12.46B |
| HBM Holdings | 10.18B |
| CStone Pharmaceuticals | 9.72B |
| Shanghai Haohai Biological Technology | 9.19B |
| CARsgen Therapeutics Holdings | 8.89B |
| Lepu Biopharma | 8.88B |